Skip to content
  • Join Us
    • Clinician Working Groups
    • Stakeholder Coalitions
  • Take Action
  • Resources
  • Events
  • Join Us
    • Clinician Working Groups
    • Stakeholder Coalitions
  • Take Action
  • Resources
  • Events

Tag: Cardiovascular|Cost Value

Comments on ICER’s Draft Evidence Report: High Cholesterol Therapies

Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community. Read the Letter

ICER Report Could Intensify Barriers for Heart Patients

Accessing innovative cardiovascular drugs may soon get harder.

Join AfPA

Ready to advance patient-centered care?
Contact Us

Quick Links

  • About AfPA
  • Coalitions
  • Events
  • Resources
  • State Chapters
  • Working Groups

Connect

  • [email protected]
  • (202) 951-7097
  • 2020 K Street NW Suite 505 Washington, D.C. 20006

Subscribe

Get the latest health policy insights directly in your inbox
By subscribing, you agree to our privacy policy and consent to receive updates about patient access advocacy.
X-twitter Facebook-square Linkedin-in Youtube
© 2026 Alliance for Patient Access. All rights reserved.
  • Privacy policy
  • Terms of service
  • Cookies settings
  • About
  • Clinician Working Groups
  • Stakeholder Coalitions
  • Resources
  • Events
  • Contact
  • About
  • Clinician Working Groups
  • Stakeholder Coalitions
  • Resources
  • Events
  • Contact
  • [email protected]
  • (202) 951-7097
  • 2020 K Street NW Suite 505 Washington, D.C. 20006
Icon-twitter-x Facebook-square Linkedin-in Youtube